Business Strategy

Build a pipeline of breakthrough drugs for both acute (hospital-based) and chronic disorders with significant unmet medical need

Tranzyme Pharma is developing first-in-class, mechanism-based therapeutics for the treatment of indications with few existing or poorly performing therapies. The Company is focused on developing drug products that address multiple therapeutic indications. 


Develop internal products to an optimal stage prior to out-licensing

Tranzyme Pharma will license certain rights to its drug development programs when proof of concept in man is achieved, or when a program may benefit from the research, development and commercialization capabilities of a partner. Through these strategic collaborations, Tranzyme will balance risk while preserving the potential for significant returns.

Seek drug discovery and development partnerships in multiple disease categories

Tranzyme's MATCH™ technology can create high potential, new drug candidates in many disease or drug target areas. Tranzyme will enter into discovery and development partnerships to leverage its proprietary macrocyclic chemistry technology and drug discovery capabilities.

To learn more about potential alliances and collaborations with Tranzyme, please contact Tranzyme's Business Development Department:

Jennifer A. Filbey, Ph.D.
Vice President, Business Development

Phone: (256) 417-8568